nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS2—type 2 diabetes mellitus	0.298	1	CbGaD
Trisalicylate-choline—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.109	0.227	CbGbCtD
Trisalicylate-choline—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.109	0.227	CbGbCtD
Trisalicylate-choline—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.1	0.209	CbGbCtD
Trisalicylate-choline—PTGS1—Nateglinide—type 2 diabetes mellitus	0.0825	0.172	CbGbCtD
Trisalicylate-choline—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0791	0.165	CbGbCtD
Trisalicylate-choline—PTGS2—leg—type 2 diabetes mellitus	0.00217	0.177	CbGeAlD
Trisalicylate-choline—PTGS2—hindlimb—type 2 diabetes mellitus	0.00194	0.158	CbGeAlD
Trisalicylate-choline—PTGS1—artery—type 2 diabetes mellitus	0.00124	0.102	CbGeAlD
Trisalicylate-choline—PTGS2—artery—type 2 diabetes mellitus	0.00119	0.0971	CbGeAlD
Trisalicylate-choline—PTGS1—endothelium—type 2 diabetes mellitus	0.00105	0.0858	CbGeAlD
Trisalicylate-choline—PTGS2—endothelium—type 2 diabetes mellitus	0.001	0.082	CbGeAlD
Trisalicylate-choline—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000572	0.0467	CbGeAlD
Trisalicylate-choline—Magnesium salicylate—PTGS2—type 2 diabetes mellitus	0.000549	0.365	CrCbGaD
Trisalicylate-choline—Magnesium salicylate—ALB—type 2 diabetes mellitus	0.00049	0.325	CrCbGaD
Trisalicylate-choline—Salsalate—PTGS2—type 2 diabetes mellitus	0.000467	0.31	CrCbGaD
Trisalicylate-choline—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.000432	0.0353	CbGeAlD
Trisalicylate-choline—PTGS1—kidney—type 2 diabetes mellitus	0.000423	0.0345	CbGeAlD
Trisalicylate-choline—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000413	0.0337	CbGeAlD
Trisalicylate-choline—PTGS2—kidney—type 2 diabetes mellitus	0.000404	0.033	CbGeAlD
Trisalicylate-choline—PTGS2—pancreas—type 2 diabetes mellitus	0.000402	0.0328	CbGeAlD
Trisalicylate-choline—PTGS1—adipose tissue—type 2 diabetes mellitus	0.000381	0.0311	CbGeAlD
Trisalicylate-choline—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000364	0.0298	CbGeAlD
Trisalicylate-choline—Nausea—Nateglinide—type 2 diabetes mellitus	0.00031	0.00204	CcSEcCtD
Trisalicylate-choline—Shock—Bromocriptine—type 2 diabetes mellitus	0.00031	0.00204	CcSEcCtD
Trisalicylate-choline—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.00031	0.00204	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000309	0.00204	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000308	0.00203	CcSEcCtD
Trisalicylate-choline—Weight increased—Losartan—type 2 diabetes mellitus	0.000308	0.00203	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000307	0.00202	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000306	0.00202	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Ramipril—type 2 diabetes mellitus	0.000306	0.00202	CcSEcCtD
Trisalicylate-choline—Hepatitis—Metformin—type 2 diabetes mellitus	0.000305	0.00201	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000304	0.002	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000303	0.00199	CcSEcCtD
Trisalicylate-choline—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000302	0.00199	CcSEcCtD
Trisalicylate-choline—Epistaxis—Irbesartan—type 2 diabetes mellitus	0.000302	0.00199	CcSEcCtD
Trisalicylate-choline—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.0003	0.00198	CcSEcCtD
Trisalicylate-choline—Pain—Sitagliptin—type 2 diabetes mellitus	0.000298	0.00196	CcSEcCtD
Trisalicylate-choline—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000298	0.00196	CcSEcCtD
Trisalicylate-choline—Urticaria—Glipizide—type 2 diabetes mellitus	0.000297	0.00196	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000295	0.00195	CcSEcCtD
Trisalicylate-choline—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000294	0.00194	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000293	0.00193	CcSEcCtD
Trisalicylate-choline—Confusional state—Glyburide—type 2 diabetes mellitus	0.00029	0.00191	CcSEcCtD
Trisalicylate-choline—Asthma—Ramipril—type 2 diabetes mellitus	0.00029	0.00191	CcSEcCtD
Trisalicylate-choline—Sweating—Losartan—type 2 diabetes mellitus	0.000289	0.0019	CcSEcCtD
Trisalicylate-choline—Oedema—Glyburide—type 2 diabetes mellitus	0.000288	0.0019	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000288	0.0019	CcSEcCtD
Trisalicylate-choline—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000288	0.00189	CcSEcCtD
Trisalicylate-choline—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.000287	0.00189	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000287	0.00189	CcSEcCtD
Trisalicylate-choline—Rash—Repaglinide—type 2 diabetes mellitus	0.000285	0.00188	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.000285	0.00188	CcSEcCtD
Trisalicylate-choline—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000285	0.00188	CcSEcCtD
Trisalicylate-choline—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000285	0.00188	CcSEcCtD
Trisalicylate-choline—Epistaxis—Losartan—type 2 diabetes mellitus	0.000284	0.00187	CcSEcCtD
Trisalicylate-choline—Headache—Repaglinide—type 2 diabetes mellitus	0.000283	0.00187	CcSEcCtD
Trisalicylate-choline—Shock—Glyburide—type 2 diabetes mellitus	0.000283	0.00187	CcSEcCtD
Trisalicylate-choline—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000283	0.00186	CcSEcCtD
Trisalicylate-choline—Flushing—Metformin—type 2 diabetes mellitus	0.000283	0.00186	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.000282	0.00186	CcSEcCtD
Trisalicylate-choline—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.00028	0.00184	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000278	0.00183	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.000278	0.00183	CcSEcCtD
Trisalicylate-choline—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000277	0.00183	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000277	0.00183	CcSEcCtD
Trisalicylate-choline—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000277	0.00182	CcSEcCtD
Trisalicylate-choline—Anorexia—Glyburide—type 2 diabetes mellitus	0.000275	0.00181	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000274	0.0018	CcSEcCtD
Trisalicylate-choline—Hepatitis—Losartan—type 2 diabetes mellitus	0.00027	0.00178	CcSEcCtD
Trisalicylate-choline—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00027	0.00177	CcSEcCtD
Trisalicylate-choline—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000269	0.00177	CcSEcCtD
Trisalicylate-choline—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000269	0.00177	CcSEcCtD
Trisalicylate-choline—Hypotension—Glyburide—type 2 diabetes mellitus	0.000269	0.00177	CcSEcCtD
Trisalicylate-choline—Nausea—Repaglinide—type 2 diabetes mellitus	0.000269	0.00177	CcSEcCtD
Trisalicylate-choline—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.000268	0.00176	CcSEcCtD
Trisalicylate-choline—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000268	0.00176	CcSEcCtD
Trisalicylate-choline—Flushing—Irbesartan—type 2 diabetes mellitus	0.000267	0.00176	CcSEcCtD
Trisalicylate-choline—Erythema—Metformin—type 2 diabetes mellitus	0.000265	0.00175	CcSEcCtD
Trisalicylate-choline—Pruritus—Glipizide—type 2 diabetes mellitus	0.000265	0.00174	CcSEcCtD
Trisalicylate-choline—Weight increased—Ramipril—type 2 diabetes mellitus	0.000264	0.00174	CcSEcCtD
Trisalicylate-choline—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000261	0.00172	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Metformin—type 2 diabetes mellitus	0.00026	0.00171	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.00026	0.00171	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000256	0.00169	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000256	0.00168	CcSEcCtD
Trisalicylate-choline—PTGS2—liver—type 2 diabetes mellitus	0.000256	0.0209	CbGeAlD
Trisalicylate-choline—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000254	0.00167	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000254	0.00167	CcSEcCtD
Trisalicylate-choline—Tinnitus—Losartan—type 2 diabetes mellitus	0.000252	0.00166	CcSEcCtD
Trisalicylate-choline—Flushing—Losartan—type 2 diabetes mellitus	0.000251	0.00165	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.00025	0.00165	CcSEcCtD
Trisalicylate-choline—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00025	0.00165	CcSEcCtD
Trisalicylate-choline—Erythema—Irbesartan—type 2 diabetes mellitus	0.00025	0.00165	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00025	0.00165	CcSEcCtD
Trisalicylate-choline—Sweating—Ramipril—type 2 diabetes mellitus	0.000248	0.00163	CcSEcCtD
Trisalicylate-choline—Dizziness—Glipizide—type 2 diabetes mellitus	0.000247	0.00163	CcSEcCtD
Trisalicylate-choline—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000247	0.00163	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000245	0.00162	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000245	0.00161	CcSEcCtD
Trisalicylate-choline—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000244	0.0016	CcSEcCtD
Trisalicylate-choline—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000242	0.00159	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000239	0.00157	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000238	0.00157	CcSEcCtD
Trisalicylate-choline—Vomiting—Glipizide—type 2 diabetes mellitus	0.000238	0.00157	CcSEcCtD
Trisalicylate-choline—Oedema—Valsartan—type 2 diabetes mellitus	0.000238	0.00156	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000237	0.00156	CcSEcCtD
Trisalicylate-choline—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000237	0.00156	CcSEcCtD
Trisalicylate-choline—Rash—Glipizide—type 2 diabetes mellitus	0.000236	0.00155	CcSEcCtD
Trisalicylate-choline—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000236	0.00155	CcSEcCtD
Trisalicylate-choline—Erythema—Losartan—type 2 diabetes mellitus	0.000235	0.00155	CcSEcCtD
Trisalicylate-choline—Oedema—Orlistat—type 2 diabetes mellitus	0.000235	0.00155	CcSEcCtD
Trisalicylate-choline—Headache—Glipizide—type 2 diabetes mellitus	0.000234	0.00154	CcSEcCtD
Trisalicylate-choline—Shock—Valsartan—type 2 diabetes mellitus	0.000234	0.00154	CcSEcCtD
Trisalicylate-choline—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000232	0.00153	CcSEcCtD
Trisalicylate-choline—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000231	0.00152	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000231	0.00152	CcSEcCtD
Trisalicylate-choline—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00023	0.00152	CcSEcCtD
Trisalicylate-choline—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00023	0.00151	CcSEcCtD
Trisalicylate-choline—Urticaria—Glyburide—type 2 diabetes mellitus	0.000229	0.00151	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000228	0.0015	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000227	0.00149	CcSEcCtD
Trisalicylate-choline—Anorexia—Valsartan—type 2 diabetes mellitus	0.000227	0.00149	CcSEcCtD
Trisalicylate-choline—Headache—Pioglitazone—type 2 diabetes mellitus	0.000225	0.00148	CcSEcCtD
Trisalicylate-choline—Nausea—Glipizide—type 2 diabetes mellitus	0.000222	0.00146	CcSEcCtD
Trisalicylate-choline—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000222	0.00146	CcSEcCtD
Trisalicylate-choline—Hypotension—Valsartan—type 2 diabetes mellitus	0.000222	0.00146	CcSEcCtD
Trisalicylate-choline—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000221	0.00146	CcSEcCtD
Trisalicylate-choline—Pain—Gliclazide—type 2 diabetes mellitus	0.000221	0.00146	CcSEcCtD
Trisalicylate-choline—Constipation—Gliclazide—type 2 diabetes mellitus	0.000221	0.00146	CcSEcCtD
Trisalicylate-choline—Rash—Glimepiride—type 2 diabetes mellitus	0.00022	0.00145	CcSEcCtD
Trisalicylate-choline—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00022	0.00145	CcSEcCtD
Trisalicylate-choline—Rash—Sitagliptin—type 2 diabetes mellitus	0.00022	0.00145	CcSEcCtD
Trisalicylate-choline—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000219	0.00144	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000219	0.00144	CcSEcCtD
Trisalicylate-choline—Headache—Glimepiride—type 2 diabetes mellitus	0.000219	0.00144	CcSEcCtD
Trisalicylate-choline—Headache—Sitagliptin—type 2 diabetes mellitus	0.000218	0.00144	CcSEcCtD
Trisalicylate-choline—Oedema—Metformin—type 2 diabetes mellitus	0.000216	0.00142	CcSEcCtD
Trisalicylate-choline—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000216	0.00142	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000216	0.00142	CcSEcCtD
Trisalicylate-choline—Flushing—Ramipril—type 2 diabetes mellitus	0.000215	0.00142	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000213	0.0014	CcSEcCtD
Trisalicylate-choline—Shock—Metformin—type 2 diabetes mellitus	0.000213	0.0014	CcSEcCtD
Trisalicylate-choline—Somnolence—Valsartan—type 2 diabetes mellitus	0.000211	0.00139	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000209	0.00138	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000209	0.00138	CcSEcCtD
Trisalicylate-choline—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000208	0.00137	CcSEcCtD
Trisalicylate-choline—Nausea—Glimepiride—type 2 diabetes mellitus	0.000207	0.00137	CcSEcCtD
Trisalicylate-choline—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000207	0.00136	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000207	0.00136	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000207	0.00136	CcSEcCtD
Trisalicylate-choline—Anorexia—Metformin—type 2 diabetes mellitus	0.000206	0.00136	CcSEcCtD
Trisalicylate-choline—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000205	0.00135	CcSEcCtD
Trisalicylate-choline—Oedema—Irbesartan—type 2 diabetes mellitus	0.000204	0.00134	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000204	0.00134	CcSEcCtD
Trisalicylate-choline—Pruritus—Glyburide—type 2 diabetes mellitus	0.000204	0.00134	CcSEcCtD
Trisalicylate-choline—Constipation—Valsartan—type 2 diabetes mellitus	0.000203	0.00134	CcSEcCtD
Trisalicylate-choline—Hypotension—Metformin—type 2 diabetes mellitus	0.000202	0.00133	CcSEcCtD
Trisalicylate-choline—Erythema—Ramipril—type 2 diabetes mellitus	0.000202	0.00133	CcSEcCtD
Trisalicylate-choline—Shock—Irbesartan—type 2 diabetes mellitus	0.000201	0.00132	CcSEcCtD
Trisalicylate-choline—Pain—Orlistat—type 2 diabetes mellitus	0.000201	0.00132	CcSEcCtD
Trisalicylate-choline—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.0002	0.00132	CcSEcCtD
Trisalicylate-choline—Rash—Bromocriptine—type 2 diabetes mellitus	0.000199	0.00131	CcSEcCtD
Trisalicylate-choline—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000198	0.00131	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000198	0.0013	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000197	0.0013	CcSEcCtD
Trisalicylate-choline—Headache—Bromocriptine—type 2 diabetes mellitus	0.000197	0.0013	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000197	0.0013	CcSEcCtD
Trisalicylate-choline—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000195	0.00128	CcSEcCtD
Trisalicylate-choline—Confusional state—Losartan—type 2 diabetes mellitus	0.000194	0.00128	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000193	0.00127	CcSEcCtD
Trisalicylate-choline—Somnolence—Metformin—type 2 diabetes mellitus	0.000192	0.00127	CcSEcCtD
Trisalicylate-choline—Oedema—Losartan—type 2 diabetes mellitus	0.000192	0.00127	CcSEcCtD
Trisalicylate-choline—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000191	0.00126	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Metformin—type 2 diabetes mellitus	0.00019	0.00125	CcSEcCtD
Trisalicylate-choline—Shock—Losartan—type 2 diabetes mellitus	0.000189	0.00124	CcSEcCtD
Trisalicylate-choline—Urticaria—Valsartan—type 2 diabetes mellitus	0.000189	0.00124	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000188	0.00124	CcSEcCtD
Trisalicylate-choline—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000187	0.00123	CcSEcCtD
Trisalicylate-choline—Urticaria—Orlistat—type 2 diabetes mellitus	0.000187	0.00123	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000186	0.00122	CcSEcCtD
Trisalicylate-choline—Constipation—Metformin—type 2 diabetes mellitus	0.000185	0.00122	CcSEcCtD
Trisalicylate-choline—Anorexia—Losartan—type 2 diabetes mellitus	0.000183	0.00121	CcSEcCtD
Trisalicylate-choline—Vomiting—Glyburide—type 2 diabetes mellitus	0.000183	0.00121	CcSEcCtD
Trisalicylate-choline—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000183	0.0012	CcSEcCtD
Trisalicylate-choline—Rash—Glyburide—type 2 diabetes mellitus	0.000182	0.0012	CcSEcCtD
Trisalicylate-choline—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000182	0.0012	CcSEcCtD
Trisalicylate-choline—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000181	0.00119	CcSEcCtD
Trisalicylate-choline—Headache—Glyburide—type 2 diabetes mellitus	0.00018	0.00119	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.00018	0.00118	CcSEcCtD
Trisalicylate-choline—Hypotension—Losartan—type 2 diabetes mellitus	0.00018	0.00118	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000178	0.00117	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000178	0.00117	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000177	0.00117	CcSEcCtD
Trisalicylate-choline—Pain—Irbesartan—type 2 diabetes mellitus	0.000175	0.00115	CcSEcCtD
Trisalicylate-choline—Constipation—Irbesartan—type 2 diabetes mellitus	0.000175	0.00115	CcSEcCtD
Trisalicylate-choline—Urticaria—Metformin—type 2 diabetes mellitus	0.000172	0.00113	CcSEcCtD
Trisalicylate-choline—Nausea—Glyburide—type 2 diabetes mellitus	0.000171	0.00113	CcSEcCtD
Trisalicylate-choline—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000171	0.00113	CcSEcCtD
Trisalicylate-choline—Somnolence—Losartan—type 2 diabetes mellitus	0.000171	0.00112	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000169	0.00111	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000168	0.00111	CcSEcCtD
Trisalicylate-choline—Pruritus—Valsartan—type 2 diabetes mellitus	0.000168	0.00111	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000167	0.0011	CcSEcCtD
Trisalicylate-choline—Confusional state—Ramipril—type 2 diabetes mellitus	0.000166	0.00109	CcSEcCtD
Trisalicylate-choline—Pruritus—Orlistat—type 2 diabetes mellitus	0.000166	0.00109	CcSEcCtD
Trisalicylate-choline—Oedema—Ramipril—type 2 diabetes mellitus	0.000165	0.00109	CcSEcCtD
Trisalicylate-choline—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000164	0.00108	CcSEcCtD
Trisalicylate-choline—Constipation—Losartan—type 2 diabetes mellitus	0.000164	0.00108	CcSEcCtD
Trisalicylate-choline—Pain—Losartan—type 2 diabetes mellitus	0.000164	0.00108	CcSEcCtD
Trisalicylate-choline—Rash—Gliclazide—type 2 diabetes mellitus	0.000163	0.00107	CcSEcCtD
Trisalicylate-choline—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000163	0.00107	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000163	0.00107	CcSEcCtD
Trisalicylate-choline—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000162	0.00107	CcSEcCtD
Trisalicylate-choline—Shock—Ramipril—type 2 diabetes mellitus	0.000162	0.00107	CcSEcCtD
Trisalicylate-choline—Headache—Gliclazide—type 2 diabetes mellitus	0.000162	0.00107	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000161	0.00106	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000159	0.00105	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000158	0.00104	CcSEcCtD
Trisalicylate-choline—Dizziness—Valsartan—type 2 diabetes mellitus	0.000157	0.00103	CcSEcCtD
Trisalicylate-choline—Anorexia—Ramipril—type 2 diabetes mellitus	0.000157	0.00103	CcSEcCtD
Trisalicylate-choline—Dizziness—Orlistat—type 2 diabetes mellitus	0.000155	0.00102	CcSEcCtD
Trisalicylate-choline—Hypotension—Ramipril—type 2 diabetes mellitus	0.000154	0.00101	CcSEcCtD
Trisalicylate-choline—Nausea—Gliclazide—type 2 diabetes mellitus	0.000154	0.00101	CcSEcCtD
Trisalicylate-choline—Pruritus—Metformin—type 2 diabetes mellitus	0.000153	0.00101	CcSEcCtD
Trisalicylate-choline—Urticaria—Losartan—type 2 diabetes mellitus	0.000153	0.00101	CcSEcCtD
Trisalicylate-choline—Vomiting—Valsartan—type 2 diabetes mellitus	0.000151	0.000995	CcSEcCtD
Trisalicylate-choline—Rash—Valsartan—type 2 diabetes mellitus	0.00015	0.000987	CcSEcCtD
Trisalicylate-choline—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00015	0.000986	CcSEcCtD
Trisalicylate-choline—Vomiting—Orlistat—type 2 diabetes mellitus	0.000149	0.000983	CcSEcCtD
Trisalicylate-choline—Headache—Valsartan—type 2 diabetes mellitus	0.000149	0.00098	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000148	0.000975	CcSEcCtD
Trisalicylate-choline—Rash—Orlistat—type 2 diabetes mellitus	0.000148	0.000975	CcSEcCtD
Trisalicylate-choline—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000148	0.000974	CcSEcCtD
Trisalicylate-choline—Headache—Orlistat—type 2 diabetes mellitus	0.000147	0.000969	CcSEcCtD
Trisalicylate-choline—Somnolence—Ramipril—type 2 diabetes mellitus	0.000146	0.000965	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000145	0.000955	CcSEcCtD
Trisalicylate-choline—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000144	0.000951	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000143	0.000943	CcSEcCtD
Trisalicylate-choline—Dizziness—Metformin—type 2 diabetes mellitus	0.000143	0.000942	CcSEcCtD
Trisalicylate-choline—Nausea—Valsartan—type 2 diabetes mellitus	0.000141	0.000929	CcSEcCtD
Trisalicylate-choline—Constipation—Ramipril—type 2 diabetes mellitus	0.000141	0.000928	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00014	0.00092	CcSEcCtD
Trisalicylate-choline—Nausea—Orlistat—type 2 diabetes mellitus	0.000139	0.000918	CcSEcCtD
Trisalicylate-choline—Vomiting—Metformin—type 2 diabetes mellitus	0.000138	0.000906	CcSEcCtD
Trisalicylate-choline—Rash—Metformin—type 2 diabetes mellitus	0.000136	0.000898	CcSEcCtD
Trisalicylate-choline—Dermatitis—Metformin—type 2 diabetes mellitus	0.000136	0.000898	CcSEcCtD
Trisalicylate-choline—Pruritus—Losartan—type 2 diabetes mellitus	0.000136	0.000895	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000136	0.000894	CcSEcCtD
Trisalicylate-choline—Headache—Metformin—type 2 diabetes mellitus	0.000136	0.000893	CcSEcCtD
Trisalicylate-choline—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000135	0.000889	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000131	0.000866	CcSEcCtD
Trisalicylate-choline—Urticaria—Ramipril—type 2 diabetes mellitus	0.000131	0.000862	CcSEcCtD
Trisalicylate-choline—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00013	0.000855	CcSEcCtD
Trisalicylate-choline—Rash—Irbesartan—type 2 diabetes mellitus	0.000129	0.000848	CcSEcCtD
Trisalicylate-choline—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000129	0.000847	CcSEcCtD
Trisalicylate-choline—Nausea—Metformin—type 2 diabetes mellitus	0.000129	0.000846	CcSEcCtD
Trisalicylate-choline—Headache—Irbesartan—type 2 diabetes mellitus	0.000128	0.000842	CcSEcCtD
Trisalicylate-choline—Dizziness—Losartan—type 2 diabetes mellitus	0.000127	0.000837	CcSEcCtD
Trisalicylate-choline—Vomiting—Losartan—type 2 diabetes mellitus	0.000122	0.000805	CcSEcCtD
Trisalicylate-choline—Nausea—Irbesartan—type 2 diabetes mellitus	0.000121	0.000799	CcSEcCtD
Trisalicylate-choline—Rash—Losartan—type 2 diabetes mellitus	0.000121	0.000798	CcSEcCtD
Trisalicylate-choline—Dermatitis—Losartan—type 2 diabetes mellitus	0.000121	0.000797	CcSEcCtD
Trisalicylate-choline—Headache—Losartan—type 2 diabetes mellitus	0.00012	0.000793	CcSEcCtD
Trisalicylate-choline—Pruritus—Ramipril—type 2 diabetes mellitus	0.000117	0.000768	CcSEcCtD
Trisalicylate-choline—Nausea—Losartan—type 2 diabetes mellitus	0.000114	0.000752	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000113	0.000742	CcSEcCtD
Trisalicylate-choline—Dizziness—Ramipril—type 2 diabetes mellitus	0.000109	0.000718	CcSEcCtD
Trisalicylate-choline—Vomiting—Ramipril—type 2 diabetes mellitus	0.000105	0.00069	CcSEcCtD
Trisalicylate-choline—Rash—Ramipril—type 2 diabetes mellitus	0.000104	0.000684	CcSEcCtD
Trisalicylate-choline—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000104	0.000684	CcSEcCtD
Trisalicylate-choline—Headache—Ramipril—type 2 diabetes mellitus	0.000103	0.00068	CcSEcCtD
Trisalicylate-choline—Nausea—Ramipril—type 2 diabetes mellitus	9.79e-05	0.000644	CcSEcCtD
Trisalicylate-choline—PTGS1—Metabolism—GCGR—type 2 diabetes mellitus	4.82e-05	0.000844	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—TNF—type 2 diabetes mellitus	4.78e-05	0.000837	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ENPP1—type 2 diabetes mellitus	4.72e-05	0.000826	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—G6PC—type 2 diabetes mellitus	4.72e-05	0.000826	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PPP1R3C—type 2 diabetes mellitus	4.72e-05	0.000826	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	4.67e-05	0.000818	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	4.66e-05	0.000816	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CDO1—type 2 diabetes mellitus	4.64e-05	0.000813	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GPD2—type 2 diabetes mellitus	4.64e-05	0.000813	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	4.64e-05	0.000812	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	4.59e-05	0.000805	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—OXCT1—type 2 diabetes mellitus	4.55e-05	0.000797	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYTB—type 2 diabetes mellitus	4.55e-05	0.000797	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	4.54e-05	0.000795	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	4.51e-05	0.00079	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SRD5A1—type 2 diabetes mellitus	4.43e-05	0.000776	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AK1—type 2 diabetes mellitus	4.43e-05	0.000776	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	4.38e-05	0.000767	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ACACA—type 2 diabetes mellitus	4.23e-05	0.000741	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—STAR—type 2 diabetes mellitus	4.23e-05	0.000741	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HSD17B3—type 2 diabetes mellitus	4.23e-05	0.000741	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC5A4—type 2 diabetes mellitus	4.09e-05	0.000716	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—MAT1A—type 2 diabetes mellitus	4.09e-05	0.000716	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	4.07e-05	0.000713	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CBS—type 2 diabetes mellitus	4.05e-05	0.00071	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ABCC8—type 2 diabetes mellitus	4.05e-05	0.00071	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TGFB1—type 2 diabetes mellitus	4.05e-05	0.000709	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	4.01e-05	0.000702	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ACACA—type 2 diabetes mellitus	4.01e-05	0.000702	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	4e-05	0.0007	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—EGFR—type 2 diabetes mellitus	3.97e-05	0.000695	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	3.96e-05	0.000693	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPP1R3C—type 2 diabetes mellitus	3.95e-05	0.000691	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ND1—type 2 diabetes mellitus	3.95e-05	0.000691	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ENPP1—type 2 diabetes mellitus	3.95e-05	0.000691	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HBA2—type 2 diabetes mellitus	3.95e-05	0.000691	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—G6PC—type 2 diabetes mellitus	3.95e-05	0.000691	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SLC5A2—type 2 diabetes mellitus	3.9e-05	0.000683	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—COX2—type 2 diabetes mellitus	3.9e-05	0.000683	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IL6—type 2 diabetes mellitus	3.86e-05	0.000676	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NCOA6—type 2 diabetes mellitus	3.83e-05	0.000671	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	3.83e-05	0.000671	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GCGR—type 2 diabetes mellitus	3.82e-05	0.00067	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TNF—type 2 diabetes mellitus	3.78e-05	0.000662	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—UCP3—type 2 diabetes mellitus	3.77e-05	0.00066	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—UCP2—type 2 diabetes mellitus	3.77e-05	0.00066	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HSD11B1—type 2 diabetes mellitus	3.77e-05	0.00066	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SLC5A2—type 2 diabetes mellitus	3.7e-05	0.000648	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	3.68e-05	0.000645	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	3.65e-05	0.00064	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—OXCT1—type 2 diabetes mellitus	3.61e-05	0.000632	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYTB—type 2 diabetes mellitus	3.61e-05	0.000632	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PCK1—type 2 diabetes mellitus	3.54e-05	0.000621	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	3.54e-05	0.000619	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SRD5A1—type 2 diabetes mellitus	3.52e-05	0.000616	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	3.49e-05	0.000611	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	3.4e-05	0.000596	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PCK1—type 2 diabetes mellitus	3.36e-05	0.000588	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—STAR—type 2 diabetes mellitus	3.36e-05	0.000588	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HSD17B3—type 2 diabetes mellitus	3.36e-05	0.000588	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ACACA—type 2 diabetes mellitus	3.36e-05	0.000588	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HK1—type 2 diabetes mellitus	3.32e-05	0.000581	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	3.32e-05	0.000581	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	3.31e-05	0.000579	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TLE4—type 2 diabetes mellitus	3.27e-05	0.000572	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CBS—type 2 diabetes mellitus	3.22e-05	0.000564	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ABCC8—type 2 diabetes mellitus	3.22e-05	0.000564	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—KCNJ11—type 2 diabetes mellitus	3.21e-05	0.000561	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HSD3B2—type 2 diabetes mellitus	3.21e-05	0.000561	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—LPA—type 2 diabetes mellitus	3.21e-05	0.000561	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GCKR—type 2 diabetes mellitus	3.21e-05	0.000561	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HK1—type 2 diabetes mellitus	3.15e-05	0.000551	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC5A2—type 2 diabetes mellitus	3.1e-05	0.000543	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—COX2—type 2 diabetes mellitus	3.1e-05	0.000543	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	3.08e-05	0.00054	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	3.08e-05	0.00054	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALDOB—type 2 diabetes mellitus	3.07e-05	0.000538	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL6—type 2 diabetes mellitus	3.05e-05	0.000534	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NCOA6—type 2 diabetes mellitus	3.04e-05	0.000533	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	3.04e-05	0.000533	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—GCKR—type 2 diabetes mellitus	3.04e-05	0.000532	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	3e-05	0.000525	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HSD11B1—type 2 diabetes mellitus	2.99e-05	0.000524	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—UCP3—type 2 diabetes mellitus	2.99e-05	0.000524	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—UCP2—type 2 diabetes mellitus	2.99e-05	0.000524	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.98e-05	0.000523	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.92e-05	0.000512	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ALDOB—type 2 diabetes mellitus	2.91e-05	0.00051	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	2.9e-05	0.000508	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.89e-05	0.000506	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GLP1R—type 2 diabetes mellitus	2.86e-05	0.0005	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PCK1—type 2 diabetes mellitus	2.81e-05	0.000493	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SPRY2—type 2 diabetes mellitus	2.78e-05	0.000487	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.77e-05	0.000485	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	2.75e-05	0.000482	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RBP4—type 2 diabetes mellitus	2.71e-05	0.000474	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.7e-05	0.000473	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	2.7e-05	0.000473	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SLC2A2—type 2 diabetes mellitus	2.67e-05	0.000467	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HK1—type 2 diabetes mellitus	2.63e-05	0.000461	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.63e-05	0.000461	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CPT1A—type 2 diabetes mellitus	2.61e-05	0.000458	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—MTR—type 2 diabetes mellitus	2.61e-05	0.000458	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	2.57e-05	0.00045	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NAMPT—type 2 diabetes mellitus	2.56e-05	0.000449	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.55e-05	0.000446	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—LIPC—type 2 diabetes mellitus	2.55e-05	0.000446	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HBA1—type 2 diabetes mellitus	2.55e-05	0.000446	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GCK—type 2 diabetes mellitus	2.55e-05	0.000446	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—LPA—type 2 diabetes mellitus	2.54e-05	0.000446	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—KCNJ11—type 2 diabetes mellitus	2.54e-05	0.000446	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HSD3B2—type 2 diabetes mellitus	2.54e-05	0.000446	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GCKR—type 2 diabetes mellitus	2.54e-05	0.000446	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP11A1—type 2 diabetes mellitus	2.53e-05	0.000443	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SLC2A2—type 2 diabetes mellitus	2.53e-05	0.000443	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SLC9A1—type 2 diabetes mellitus	2.49e-05	0.000435	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MTR—type 2 diabetes mellitus	2.48e-05	0.000434	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CETP—type 2 diabetes mellitus	2.46e-05	0.00043	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.45e-05	0.000428	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALDOB—type 2 diabetes mellitus	2.44e-05	0.000427	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NAMPT—type 2 diabetes mellitus	2.43e-05	0.000425	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—GCK—type 2 diabetes mellitus	2.41e-05	0.000423	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IAPP—type 2 diabetes mellitus	2.4e-05	0.00042	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.37e-05	0.000415	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SLC9A1—type 2 diabetes mellitus	2.36e-05	0.000413	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.32e-05	0.000407	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.3e-05	0.000402	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.29e-05	0.000401	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SREBF1—type 2 diabetes mellitus	2.28e-05	0.0004	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PSMD6—type 2 diabetes mellitus	2.28e-05	0.0004	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SNAP25—type 2 diabetes mellitus	2.28e-05	0.0004	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GLP1R—type 2 diabetes mellitus	2.27e-05	0.000397	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CTGF—type 2 diabetes mellitus	2.24e-05	0.000393	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HMGCR—type 2 diabetes mellitus	2.22e-05	0.000389	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HMGA1—type 2 diabetes mellitus	2.21e-05	0.000387	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.19e-05	0.000384	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ADRA2A—type 2 diabetes mellitus	2.17e-05	0.000381	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PSMD6—type 2 diabetes mellitus	2.16e-05	0.000379	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SNAP25—type 2 diabetes mellitus	2.16e-05	0.000379	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC2A2—type 2 diabetes mellitus	2.12e-05	0.000371	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CYBA—type 2 diabetes mellitus	2.1e-05	0.000367	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP2E1—type 2 diabetes mellitus	2.09e-05	0.000366	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CPT1A—type 2 diabetes mellitus	2.07e-05	0.000363	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—MTR—type 2 diabetes mellitus	2.07e-05	0.000363	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SLC2A1—type 2 diabetes mellitus	2.07e-05	0.000362	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP1A2—type 2 diabetes mellitus	2.07e-05	0.000362	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NAMPT—type 2 diabetes mellitus	2.03e-05	0.000356	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CALCA—type 2 diabetes mellitus	2.03e-05	0.000355	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.02e-05	0.000354	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HBA1—type 2 diabetes mellitus	2.02e-05	0.000354	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—LIPC—type 2 diabetes mellitus	2.02e-05	0.000354	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GCK—type 2 diabetes mellitus	2.02e-05	0.000354	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.01e-05	0.000353	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP11A1—type 2 diabetes mellitus	2.01e-05	0.000352	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2e-05	0.000351	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GCG—type 2 diabetes mellitus	1.98e-05	0.000347	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.98e-05	0.000347	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC9A1—type 2 diabetes mellitus	1.97e-05	0.000345	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SLC2A1—type 2 diabetes mellitus	1.96e-05	0.000343	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CETP—type 2 diabetes mellitus	1.95e-05	0.000342	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOS1—type 2 diabetes mellitus	1.93e-05	0.000338	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.91e-05	0.000335	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TCF7L2—type 2 diabetes mellitus	1.91e-05	0.000334	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SLC2A4—type 2 diabetes mellitus	1.88e-05	0.000329	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.82e-05	0.000318	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PSMD6—type 2 diabetes mellitus	1.81e-05	0.000317	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SREBF1—type 2 diabetes mellitus	1.81e-05	0.000317	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SNAP25—type 2 diabetes mellitus	1.81e-05	0.000317	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CTGF—type 2 diabetes mellitus	1.78e-05	0.000312	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HMGCR—type 2 diabetes mellitus	1.76e-05	0.000309	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.74e-05	0.000305	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ADRA2A—type 2 diabetes mellitus	1.73e-05	0.000302	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.71e-05	0.000299	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GNB3—type 2 diabetes mellitus	1.71e-05	0.000299	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HMOX1—type 2 diabetes mellitus	1.7e-05	0.000298	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CAT—type 2 diabetes mellitus	1.68e-05	0.000294	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP2E1—type 2 diabetes mellitus	1.66e-05	0.00029	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP1A2—type 2 diabetes mellitus	1.64e-05	0.000287	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC2A1—type 2 diabetes mellitus	1.64e-05	0.000287	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TGFBR2—type 2 diabetes mellitus	1.63e-05	0.000286	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—APOB—type 2 diabetes mellitus	1.63e-05	0.000285	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	1.6e-05	0.00028	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTM1—type 2 diabetes mellitus	1.58e-05	0.000277	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	1.58e-05	0.000277	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	1.57e-05	0.000275	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	1.57e-05	0.000275	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—LPL—type 2 diabetes mellitus	1.55e-05	0.000272	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APOB—type 2 diabetes mellitus	1.54e-05	0.00027	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ADCY5—type 2 diabetes mellitus	1.52e-05	0.000266	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GPX1—type 2 diabetes mellitus	1.52e-05	0.000265	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CD36—type 2 diabetes mellitus	1.48e-05	0.000259	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—LPL—type 2 diabetes mellitus	1.47e-05	0.000258	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.46e-05	0.000255	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	1.44e-05	0.000253	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—MTHFR—type 2 diabetes mellitus	1.4e-05	0.000245	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	1.38e-05	0.000242	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PPARA—type 2 diabetes mellitus	1.37e-05	0.00024	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CCR5—type 2 diabetes mellitus	1.36e-05	0.000238	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	1.35e-05	0.000237	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.35e-05	0.000237	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	1.35e-05	0.000236	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	1.33e-05	0.000233	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	1.33e-05	0.000233	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	1.33e-05	0.000232	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	1.31e-05	0.000229	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	1.3e-05	0.000228	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	1.29e-05	0.000226	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	1.29e-05	0.000225	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	1.26e-05	0.000221	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IRS2—type 2 diabetes mellitus	1.26e-05	0.000221	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	1.26e-05	0.00022	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CALM1—type 2 diabetes mellitus	1.24e-05	0.000217	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APOE—type 2 diabetes mellitus	1.23e-05	0.000216	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	1.23e-05	0.000216	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APOA1—type 2 diabetes mellitus	1.22e-05	0.000214	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	1.21e-05	0.000211	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	1.2e-05	0.000211	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	1.17e-05	0.000205	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.16e-05	0.000203	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOS2—type 2 diabetes mellitus	1.15e-05	0.000201	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	1.13e-05	0.000199	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—INS—type 2 diabetes mellitus	1.11e-05	0.000195	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	1.11e-05	0.000194	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IRS1—type 2 diabetes mellitus	1.1e-05	0.000193	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	1.09e-05	0.000191	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	1.06e-05	0.000185	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—INS—type 2 diabetes mellitus	1.05e-05	0.000185	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	1.04e-05	0.000182	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	1.03e-05	0.000181	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	1.02e-05	0.000179	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	1.02e-05	0.000179	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AKT2—type 2 diabetes mellitus	1.02e-05	0.000179	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	9.76e-06	0.000171	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	9.76e-06	0.000171	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	9.69e-06	0.00017	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	9.25e-06	0.000162	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOS3—type 2 diabetes mellitus	9.25e-06	0.000162	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	9.01e-06	0.000158	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	8.92e-06	0.000156	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—INS—type 2 diabetes mellitus	8.83e-06	0.000155	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	8.1e-06	0.000142	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	7.75e-06	0.000136	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	7.75e-06	0.000136	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SRC—type 2 diabetes mellitus	6.84e-06	0.00012	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	6.12e-06	0.000107	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—EGFR—type 2 diabetes mellitus	6e-06	0.000105	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IL6—type 2 diabetes mellitus	4.61e-06	8.07e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	4.49e-06	7.85e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AKT1—type 2 diabetes mellitus	4.25e-06	7.45e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	3.56e-06	6.24e-05	CbGpPWpGaD
